1. AB1204 COST-EFFECTIVENESS OF ABATACEPT IN SPAIN IN SEROPOSITIVE BIOLOGIC-NAÏVE EARLY RHEUMATOID ARTHRITIS PATIENTS WITH SHARED EPITOPE. (2nd June 2020) Authors: Rodríguez-Heredia, J. M.; Verburg-Baltussen, L.; Devender, D.; Durno, N.; Sanchez, C.; Ray, N.; Treur, M.; Zhuo, J. Journal: Annals of the rheumatic diseases Issue: Volume 79(2020)Supplement 1 Page Start: 1893 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. SAT0170 COMPOSITE OF RELEVANT ENDPOINTS FOR SJÖGREN'S SYNDROME (CRESS). (2nd June 2020) Authors: Arends, S.; Van Nimwegen, J. F.; Verstappen, G. M.; Vissink, A.; Ray, N.; Kroese, F. G. M.; Bootsma, H. Journal: Annals of the rheumatic diseases Issue: Volume 79(2020)Supplement 1 Page Start: 1026 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. THU0160 THE EFFECT OF HLA-DRB1 RISK ALLELES ON THE CLINICAL EFFICACY AND SAFETY OF ABATACEPT IN SEROPOSITIVE, BIOLOGIC-NAÏVE PATIENTS WITH EARLY, MODERATE-TO-SEVERE RA TREATED WITH ABATACEPT OR ADALIMUMAB: DATA FROM THE OPEN-LABEL SWITCH PERIOD OF THE HEAD-TO-HEAD SINGLE-BLINDED 'EARLY AMPLE' TRIAL. (2nd June 2020) Authors: Rigby, W.; Buckner, J.; Bridges, Jr., S. L.; Nys, M.; Gao, S.; Polinsky, M.; Ray, N.; Bykerk, V. Journal: Annals of the rheumatic diseases Issue: Volume 79(2020)Supplement 1 Page Start: 295 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗